Fruquintinib MoA and Toxicity Profile Overview
Key safety considerations for the use of fruquintinib are explored.
Source: onclive.com
Toxicity Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Toxicity Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Toxicity Profile Today - Breaking & Trending Today
Key Considerations for Treating Patients Diagnosed With CLL and SLL
Medical experts provide their final thoughts regarding key treatment considerations for CLL and SLL.
Source: ajmc.com
Randomized Phase 3 Study of First-line Selpercatinib vs Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC: LIBRETTO-431
Expert oncologist Benjamin Levy, MD, shares data from the LIBRETTO-431 trial comparing selpercatinib to chemotherapy plus pembrolizumab in RET fusion-positive NSCLC following ESMO 2023.
Source: onclive.com
Datopotamab Deruxtecan (Dato-DXd) vs Chemotherapy for Patients with Metastatic HR+/HER2– BC: Primary Results from the Randomized Phase III TROPION-Breast01 Trial
Expert oncologist Aditya Bardia, MD, reflects on data from the TROPION-Breast01 trial of dato-DXd versus chemotherapy in metastatic HR+/HER2– breast cancer following ESMO 2023.
Source: onclive.com
The Evolving Treatment Landscape of Small Cell Lung Cancer
Closing out their program on small cell lung cancer management, Laurent Greiller, MD, and Christian Grohé, MD, highlight what excites them most about the evolving treatment paradigm.
Source: onclive.com